The Gilgamesh Project
by Andrew Sokar, 2005 (email: slowsubversion@yahoo.com)
With multiple awards to his name for cancer research, this childhood
prodigy was silenced when his forbidden science began closing in on the
secret of eternal life.
The ability to deal effectively with diseases such as cancer and the
consequences of the aging process remains one of the last major challenges
for biomedical science. In order to meet this challenge, it is pivotal
that we understand the underlying mechanisms for the cell growth cycle,
i.e. why cells grow and divide, why they undergo a process known as differentiation
(why and how identical embryonic cells become mature liver, skin, brain
cells, etc.) and why, ultimately, cells lapse into senescence and die-causing
the metabolic decline and death of the organism.
Problems such as these have obsessed me since childhood and have fired
a passionate interest in chemistry and biology long before I enrolled
in my first college chemistry course. Considering the extreme human, social
and economic costs of diseases such as cancer, heart disease and illnesses
associated with advancing age, I could be forgiven for thinking during
my high school years that a career devoted to solving these problems was
the noblest pursuit possible. If someone had told me that vested interests
did not want solutions to these most pressing of medical problems, I would
have considered them a delusional conspiracy nut. However, my experiences
have me permanently disabused of this notion.
In this article, I wish to relate the incredible odyssey that has been
my life and some details of the medical research that I have undertaken.
I believe that this research, if taken to its logical conclusion, stands
a good chance of yielding nontoxic treatments for various forms of cancer
and also for prolonging the human life span-possibly indefinitely. Instead
of being lauded for these achievements, I have had my education and career
in the medical sciences derailed and my life essentially ruined.
There are many lessons to be learned from my experiences that would
be worthy of a Hollywood thriller. The first is just how precariously
close we stand to bringing the fountain of youth out of the realm of mythology
and into the laboratory and ultimately, the clinic-the clues to this endeavor
being provided by some of the lowliest (and annoying) organisms on earth.
The second lesson is just how committed the medical (and possibly political)
establishments are to preventing this from happening and lastly, how deeply
the tentacles of vested interests (both personal and institutional) penetrate
the hearts and minds of many doctors, administrators and medical educators
and function to beat down any type of nonconformist creativity which challenges
the status quo.
THE EARLY YEARS
I live in the Midwestern United States where I also grew up and received
my education. I currently possess a Bachelor of Science, majoring in biology,
and hold a master's degree in political science/international trade.
While my classmates in high school were attending ball games and doing
what other high schoolers do, I was performing synthetic organic chemistry
in a makeshift lab in my home. Developing novel nontoxic agricultural
chemicals for the control of pests was my initial preoccupation. Later
I became interested in creating nontoxic modalities for the treatment
of cancer. These interests were shaped by an unconventional junior high
school biology teacher who encouraged in vivo experimentation (apologies
to anti-vivisectionist readers) and pressed students to do independent
research to solve medical problems.
It was during my high school years that I entered and won virtually
every science fair with the various projects that I was undertaking. During
my senior year, I won first place in my state science fair and received
the state medical association's certification of distinction for designing
novel classes of antineoplastics (anticancer drugs). I was published professionally,
received the American Chemical Society Award, my city's Engineering
and Scientific Society award and was inducted into my state's Academy
of Science as well as into the New York Academy of Sciences and the American
Association for the Advancement of Science before graduating from high
school.
In college I continued in my pursuits to unravel the mysteries of how
cancer cells develop and metastasise. As it was unusual for undergraduate
students to develop and run their own projects, I was fortunate to work
with faculty members in my biology and chemistry departments who gave
me free run of their facilities. This research led to the development
of new classes of compounds which could almost completely block invasion
(the process by which cancer cells migrate into healthy tissue). These
compounds were essentially nontoxic I obtained funding for this research
through a local oncologist and his hospital, as well as from my university's
foundation. My research was featured on local television and in newspapers
and I received several accolades, including the Who's Who Among Students
in American Universities and Colleges Award. Thus, upon receiving my bachelor's
degree I had every reason to suspect a successful passage through medical
school and a productive career in medical research.
Upon entering medical school, I again had the fortune of working with
a faculty member who understood the potential of my work and gave me any
assistance that he could render. I was funded by my oncologist acquaintance
as well as through grant money from the American Cancer Society and other
government-funded organizations. I became steadily more engrossed in the
mysteries of the cell growth cycle and continued synthesizing novel classes
of cell growth regulators that eventually led me to develop an entirely
new perspective on such issues as the human life span, cancer and other
illnesses that my medical school professors were presenting as unrelated
phenomena. I now present this work in an abbreviated form to facilitate
understanding by readers without biomedical backgrounds.
UNRAVELING THE MYSTERIES OF THE AGES
Although the stages of the cell growth cycle and the cellular and histological
transformations that accompany them are fairly well-known to medical science,
the biochemical mechanisms that bring these changes about are poorly defined
at best. This is why current therapies for disease states which entail
rapid and uncontrolled cell division (such as cancer), consist mainly
of poisoning the offending cells with toxic drugs (chemotherapy), radiation
(radiotherapy), or removing them through surgery.
Our understanding of the underlying mechanisms for the aging process
leaves even more to be desired. We have virtually no therapies today that
can effectively halt or even slow the vaunted biological clock. All we
can hope to do is to cover up the signs of aging through various cosmetic
modalities and to treat various age-related maladies (arteriosclerosis,
heart disease, etc.,) with therapeutic regimens which address symptoms
rather than ultimate causes.
To anyone who has had to care for patients afflicted with the debilitating
sequelae of aging or the horrendous consequences of life-threatening cancers,
this is a wholly unsatisfactory state of affairs that cries out for new
insights and approaches.
Anyone who identifies the precise factors that regulate what cells do
at specific points in the cell growth cycle will have achieved a quantum
leap in our understanding not only of the genesis of cancer but also of
the age-old question concerning why animals, including humans, age and
ultimately die. Such knowledge will not only enable medical science to
safely and effectively treat many disease states which today remain enigmatic,
but also has profound ramifications for the cosmetic industry.
CURRENT STATE OF LONGEVITY RESEARCH
In order to overcome the limitations of current orthodoxies regarding
cell growth and differentiation, it is necessary to briefly review what
those orthodoxies are. Within the appropriate body of scholarship dealing
with these issues, there have been two basic schools of thought as to
what causes cell senescence, cell death and the dysfunctions associated
with neoplastic disease (e.g. cancer). The currently dominant one is the
free-radical approach.
Reduced to its most basic form, this view holds that cellular dysfunctions,
which lead to cancer as well as aging and eventual cell death, are caused
by the destructive action of environmental free radicals upon various
important cellular components such as DNA. In this fatalistic view, aging
can be understood as an irreversible and inevitable accumulation of cellular
damage. It is my belief that this view is at least partially wrong.
I was once told that research into prolonging the human life span was
futile because "every living thing has to grow old and die".
Yet, this fatalistic generalization is patently untrue. Many unicellular
organisms are effectively immortal and reproduce by dividing indefinitely,
only succumbing to environmental catastrophes-such as the Clorox bleach
in your washing machine.
Likewise, there are multicellular organisms for which the concept of
growing old is meaningless. Giant sequoia trees can be thousands of years
old-yet keep on growing and producing vigorous and functional leaves and
internal structures such as xylem and phloem year after year-being felled
only by lightning strikes or chain saws. Certain crustaceans such as lobsters
grow bigger but do not manifest the age-related declines in reflexes and
physiological parameters that plague humans and other animals.
Entomologists have long known that hormonal manipulation can prevent
metamorphosis and keep insects in the juvenile state indefinitely. This
knowledge has formed the basis for insecticide design.
Likewise, hormonal cues control the development of plants by affecting
the proliferation and differentiation of plant cells. Auxin-class herbicides,
such as the ubiquitous 2,4-dichlorophenoxyacetic acid (2,4-D) have been
used for eradicating dandelions from lawns for decades. These substances
cause discordant cell growth and differentiation which leads to fatal
morphological changes and physiological dysfunctions. Considering how
important such hormonal systems are to the survival of such a diverse
group of organisms, I reasoned that mammals possess systems (even if in
a vestigial state) which are functionally analogous, even if the specific
chemistry may differ.
A second approach to understanding aging holds that cell growth, differentiation,
aging and death are not the sole result of accumulated cellular damage
or of some unstoppable biological clock which resides exclusively within
cells, but that these are instead hormonally mediated phenomena which
result from the interaction of a cell's genes with chemical substances
present in the extracellular matrix and produced in remote locations in
the body.
This theory is supported by various lines of converging evidence, including
research done on the rare disease progeria, a syndrome in which various
endocrine glands malfunction and the victim rapidly ages and usually dies
before the chronological age of twenty.
This devastating and poorly understood disease strongly indicates that
the biological clock can be reset and speeded-up, and that this speeding
up is associated with the failure of the pineal gland (a pea-sized gland
which lies at the center of the brain), as well as the entire hypothalamic-pituitary
axis. The failure of these glands to secrete vital hormones then causes
the degenerative changes throughout the body commonly associated with
aging, only much sooner than in healthy individuals who lack the particular
genetic defects associated with progeria.
My own research, both in the library and the laboratory, has led me
to gradually put such observations together with findings from other lines
of investigation. For instance, it is now acknowledged that the hormone
melatonin-secreted by the pineal gland-plays a role not only in the regulation
of the sleep-wake cycle, but also in prolonging life span and in some
cases, halting and even reversing some of the symptoms of aging in laboratory
animals and humans. The hormone also has anticancer activity. Such research,
mostly performed in Europe, is amply cited in Dr Walter Pierpaoli's
1995 bestseller The Melatonin Miracle, and need not be dealt with in depth
here.1
Since melatonin is already a commonly sold health supplement, it cannot
be patented by pharmaceutical companies and consequently has marshaled
little interest from the medical establishment, at least on this side
of the Atlantic. However, this is irrelevant from the perspective of my
own. I believe that melatonin is an important, but relatively small piece
of the overall puzzle and my work has taken this line of research beyond
DR Pierpaoli's discoveries into wholly uncharted territory.
Synthesizing this diverse basic research with the results of my own
work in cell culture and in vivo, I have formulated the following general
conclusions:
1. Melatonin's anti-aging and anticancer effects are at least in
part due to the fact that this hormone, after it leaves the pineal gland
(where it is made), travels to the thymus gland located behind the breastbone
and possibly other endocrine glands where it functions as a "releasing
hormone" and modulates the synthesis of at least two other chemically
distinct hormones unacknowledged by medical science which I will label
only as hormone "X" and hormone "Y" for our purposes
here. I have identified the chemical structures of these substances.
2. It is both the relative and absolute ambient levels of hormones X
and Y in the body that modulate cellular growth, aging and differentiation
phenomena. This effect is in turn probably modulated by melatonin and
at least one trace metal or its organometallic complexes. Preliminary
indications are that these interactions are complex and remain largely
unknown due to the limitations in funds and facilities under which my
previous work has been carried out. The production of these substances
is probably governed by complex feedback loops that involve the sex hormones,
thyroid hormones, etc. Elucidating these relationships must remain one
goal for future research.
3. The thymus gland begins the process of involution after the chronological
age of 20-30 years in humans. The pineal also calcifies and deteriorates.
That is why CT and NMR scans of the heads of older individuals reveal
a white pea-sized object in the basal area of the brain which I have seen
many people mistake for alien implants. I submit that the deterioration
of these glands precipitates a deflection in the concentrations of hormone
X, hormone Y, or both. The magnitude and direction (up or down) of these
deflections is unknown, but is probably downward.
4. It is this perturbation in the levels of hormones X and/or Y that
triggers cell senescence and eventual death, causing tissues to stop turning
over and precipitating the physical declines associated with aging Since
one of these hormones is involved in maintaining cells in a differentiated
state, this could provide the long-awaited answer as to why cancer prevalence
in general increases as we age, and also why sexual differentiation and
other tissue differentiation declines in the same interval.
5. Seemingly intractable problems can only be solved by reinterpreting
the problems in novel ways. Cancer cells can be thought of as normal cells
which have reverted to a de-differentiated state-i.e. they resemble rapidly
dividing, undifferentiated embryonic cells rather than the mature, slowly
dividing, properly behaving normal cells of the tissues from which they
derive. It is also known to researchers that cancer cells are effectively
immortal; if given a proper environment, they can live and reproduce indefinitely,
just as can bacteria and certain types of plant and fungal cells. This
finding alone indicates that aging and death are not the inevitable fates
that they are made out to be, but are instead the results of a program
which can be altered. Although little has been made of this by conventional
researchers, it strongly suggests that cancer is not a disease state,
but a developmental problem, just as is aging Cancer cells are not behaving
badly, they are just behaving in a manner inappropriate for their age.
It is, in other words, a problem with the biological clock. Since melatonin
is one of the substances that modulates the biological clock, this would
explain melatonin's anticancer effects and also suggested to me that
hormones X and Y might have similar effects.
6. Since the chemical structures of both hormones X and Y are attainable
by traditional means of organic synthesis, their manufacture is relatively
straightforward. As is also the case with many other currently acknowledged
hormones such as the oestrogens and progestins, it is possible to synthesize
relatively low molecular weight analogues of hormones X and Y which retain
the parent molecule's biological activity. I have prepared several
analogues of this type. These compounds show the same cell growth altering
abilities of the parent molecules although the resources available to
me did not facilitate the kind of evaluation necessary to reach detailed
conclusions of the precise actions of these compounds.
7. I have developed other compounds whose chemical structure is quite
different from that of either hormones X or Y that seem to have similar
effects on cancer cells.
8. The exact mechanism of action of these compounds must at this point
remain an object of speculation, since I did not possess the funds or
the facilities to properly investigate this issue. Based on the chemical
structure of the compounds, however, it is reasonable to assume that,
on a cellular level, they act in a manner similar to that of steroid hormones
and retinoids (such as vitamin A). This means that they probably penetrate
the cell membrane and are then translocated to the nucleus where they
either promote or inhibit the expression of genes which regulate the cell
growth cycle. This is a much more sophisticated approach and stands in
total contradistinction to the mode of action of virtually all existing
anticancer drugs which are really little more than cellular poisons designed
to kill off all rapidly dividing cells. Such a shotgun approach is responsible
for the sometimes horrendous side effects associated with conventional
chemotherapy.
The compounds that I have developed have obvious application in the
nontoxic therapy of cancer and other neoplastic diseases. They also threaten
to give medical science completely new insights into the interaction of
the aging process with various disease states. If the melatonin-hormone
X-hormone Y axis is indeed responsible for regulating what cells do at
particular stages in their life cycle, then we can explain why, for instance,
certain cancers tend to occur at particular points in people's lives.
As we age, perturbations in the levels of hormones X and Y occur. The
hypothesis would predict the incidence of cancer to vary over the span
of a person's life as well. Indeed, that is precisely what we observe
clinically. As we age, the incidence of various cancers increases. This
may be due to the fact that the levels of hormones X and/or Y are no longer
sufficient to maintain certain cells in a differentiated state, or that
the immune system, whose own cells depend on specific amounts of X and
Y, can no longer perform their function of eliminating cancer cells properly.
Finally, although it is too early to be talking seriously about a fountain
of youth, I believe that hormones X and Y represent the first steps toward
unraveling the mystery of why certain organisms and tissues age. Unlike
melatonin, the compounds that I have synthesized represent the first patentable
drugs that actually have the potential of reversing or at least slowing
the much-dreaded biological clock. They are the first nonsteroidal, non-proteinaceous,
non-retinoid hormonally active substances other than melatonin and thyroid
hormone known to affect cell growth and differentiation in higher animals.
Furthermore, I have discovered that analogues of both hormones X and
Y exist in nature and can be prepared, for example, from certain plants.
These substances can be incorporated into over-the-counter products such
as cosmetics and vitamin preparations without the difficulty of surmounting
regulatory hurdles. The impact, for instance, of a wrinkle cream which
actually thickens the skin and returns cell turnover rates to levels found
in a twenty-year-old should be obvious, especially since today's cosmetic
preparations are mainly designed to cover up the effects of aging
This leads me to question whether ancient legends of fantastic life
span for humans may not have a basis in reality. For example, thousands
of years prior to the biblical era, a Sumerian legend relates the tale
of a hero-type figure by the name of Gilgamesh who traveled far and wide
in his quest for eternal life. He finally found a plant growing under
water that was able to bestow the immortality that Gilgamesh sought. As
the tale goes, however, instead of consuming the plant, he fell asleep.
During his slumber, a snake ate the plant-hence the mythological explanation
for snakes constantly shedding and renewing their skin. The moral lesson
of the story is, I suppose, "you snooze, you lose". Due to Gilgamesh's
carelessness, humankind was denied the secret of eternal life.2 Alas,
mythological descriptions of the "plant," if that is what it
was, are not sufficient to make a positive identification.
MEDICAL SCHOOL REALPOLITIK
One would have thought that a student capable of doing research such
as this would be a cause for great enthusiasm at any medical school. My
faculty advisor described me as "the most motivated student he has
ever had." Alas, however, I would soon learn that there were individuals
who considered me a threat rather than a prodigy, and I was soon to be
plunged into a confrontation with forces that, at the time, I could not
comprehend.
Between my first and second year of medical school, I was summoned to
the office of a school administration official. Conversation quickly turned
to my research. This raised my interest, as this official's duties
did not include oversight of student research programs. He declined to
answer when I asked the identity of the person that had informed him of
my work. He asked why I had decided to create my own research project
rather than simply signing on to one of the many existing projects offered
by faculty members. This was, in his words "what most students did."
I answered that I was not "most" students and that I had entered
medicine because I wanted to find new solutions to problems that conventional
research had failed to find. Rather than eliciting praise and encouragement,
my answer only seemed to make him impatient and agitated. He inquired
as to what was wrong with the available research projects. I responded
that they were mundane and too limited by conventional paradigms to yield
anything of importance in our battle with disease. I now went on the offensive
and asked what was wrong with my research, especially in light of the
fact that I was bringing money and positive publicity to the school. He
replied that "of course there was nothing wrong", and this concluded
our meeting. I could not help but be left with the impression that this
official did not accomplish his aims. My inquiries to other students revealed
that no one else had undergone such an experience.
This encounter was a turning point in my sojourn through medical school
and the subsequent campaign of behind-the-scenes persecution and harassment
leveled against me left me thinking that someone was taking lessons from
the Malleus Maleficarum.
One day I was summoned to the dean's office and told that there
was "something wrong" with my performance in a particular class.
Since my grades had been good in this class up till that point, I was
taken aback. I asked the dean to tell me precisely what I was doing wrong
and who had made the criticism. I also asked why the person making the
complaint had taken it to the dean instead of addressing me directly as
per school protocol. He refused to answer and became agitated. I replied
that if indeed I was doing something wrong I had the right to know the
precise nature of the complaint as well as the identity of the person
making it. The dean's reply was that I had no such right because his
office was not a courtroom. This was to become a fairly standard line
of defense for the medical school administration.
Despite my initial good grades and evaluations, the situation deteriorated
as I progressed through clinical clerkships. Despite the fact that my
performance outshone that of many other students, I found myself receiving
negative evaluations. Many of these evaluations were from individuals
that I never served under, and hence, were pure fabrication. On other
evaluation forms, the signature of the evaluator was either absent altogether
or was so illegible that even the clerkship coordinator claimed not to
know who the person was. This was an obvious attempt to shield the individual
from litigation. Protesting this kind of outright fraud to medical school
administration fell on deaf ears, and only resulted in new criticism charging
that I was being "defensive." In classic witch-hunt fashion,
any attempts by me to show that the charges against me were false were
only reinterpreted as additional evidence of my guilt or even psychopathology.
I was referred to a psychologist and put through a battery of personality
inventories. When these came back normal, the school administration simply
ignored the results and proceeded to make me jump through an infinite
series of new hoops in order to make me appreciate my status as persona
non-grata. This treatment finally resulted in my leaving medical school
part way through my third year. My antagonists realized that I could not
afford legal aid and thus felt secure that their machinations could not
be effectively countered.
Other more mysterious goings-on seemed to swirl around my research while
at medical school. One faculty member refused to address me in the halls
and made a point of walking out during conferences when I presented my
research. On more than one occasion, I entered my lab to find that my
possessions had been searched. To top things off, I received phone calls
from someone claiming to be my friend. This person informed me that things
would "only get worse" for me at medical school unless I "stopped
playing God". He refused to give his name or to explain precisely
what he meant by his admonition.
As one can imagine, my leaving medical school was like lifting a huge
weight from my shoulders, despite the fact that I had to discontinue my
research. The oncologist that I had worked with later perished ostensibly
of a heart attack while on vacation.
Since I cannot show that this was anything but a natural occurrence,
I leave it to the reader to decide. After his death, the hospital where
he was employed no longer funded my project citing "other priorities".
When all is said and done, what are we to make of all this? Was I the
target of industrial espionage? If so, they got nothing, as I have always
made a point of carrying my lab notebooks with me at all times and even
my faculty advisor was not made privy to the chemical formulas of the
compounds that I was developing.
Was this something entirely different? Was it an attempt to simply quash
my research? If so, did this involve only officials at the medical school
or did it go higher? What could have evoked such a concerted hate campaign
against, of all people, a lowly medical student? Did "they"
know something about the direction and ramifications of my research that
even I did not know at the time?
Given the vitriol directed against me, I cannot help but think that
I am on the right track-to something. I suppose that I should thank my
tormentors for inadvertently confirming what they did not let me have
time to confirm in the lab.
If the goal of the powers that be was to marginalize me, then they have
succeeded, at least for the time being-I am unemployable and my life has
been reduced to financial ruin. I have pursued education in other fields.
I am currently attempting to pursue my research privately since it remains
patentable. I have made arrangements that all proprietary details of the
research be made public in the event of my untimely demise, although I
believe that my tormentors have been quite happy keeping me jobless and
impoverished.
Since becoming an avid NEXUS reader a couple of years ago, I have interpreted
my plight in a different light and have begun to ask questions that would
never have occurred to me in medical school. Up until recently, I have
operated under the naïve premise that the purpose of the health care
industry was to eliminate disease and promote human well being. NEXUS
readers know better. I leave readers with the following questions and
welcome feedback: What would the implications be for the health care juggernaut
if most illnesses associated with advancing age could be eliminated by
having everyone take one pill daily? What would happen to our beleaguered
social security system if the human life span could be doubled? What would
be the impact on organized religion if one of the two certainties of life-i.e.
death-was no longer a certainty? 8
About the Author:
Andrew Sokar is a biologist who lives in the Midwestern US. He has a
Bachelor of Science, majoring in biology and a master's degree in
political science with a specialization in international trade, for which
he graduated with high distinction. He continues to pursue his research
independently, especially into the over-the-counter applications for his
rejuvenation technology. He welcomes correspondence at: slowsubversion@yahoo.com.
End Notes:
1. Walter Pierpaoli, William Regelson and Carol Colman, 1995, The Melatonin
Miracle, Pocket Books, New York. See also William Regelson and Carol Colman,
1996, The Superhormone Promise, Pocket Books, New York
2. N.K. Sanders, 1972, The Epic of Gilgamesh, Penguin, London
Extracted from Nexus Magazine, Volume 12, Number 4 (June - July 2005)
PO Box 30, Mapleton Qld 4560 Australia. editor@nexusmagazine.com
Telephone: +61 (0)7 5442 9280; Fax: +61 (0)7 5442 9381
From our web page at: www.nexusmagazine.com
|